South America Prostate Cancer Nuclear Medicine Market to 2028 - By Size, Share, Growth by End User and Forecast| Business Market Insights

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. South America Prostate Cancer Nuclear Medicine Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. South America Prostate Cancer Nuclear Medicine Market – Key Market Dynamics

5.1 Growth Drivers

5.2 Market Opportunities

5.3 Future Trends

5.4 Impact of Drivers and Restraints

6. South America Prostate Cancer Nuclear Medicine Market Regional Analysis

6.1 South America Prostate Cancer Nuclear Medicine Market Overview

6.2 South America Prostate Cancer Nuclear Medicine Market Revenue 2020-2028 (US$ Million)

6.3 South America Prostate Cancer Nuclear Medicine Market Forecast Analysis

7. South America Prostate Cancer Nuclear Medicine Market Analysis – by Type

7.1 PET

7.1.1 Overview
7.1.2 PET: South America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2031 (US$ Million)

7.2 SPECT

7.2.1 Overview
7.2.2 SPECT: South America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2031 (US$ Million)

8. South America Prostate Cancer Nuclear Medicine Market Analysis – by PET Product

8.1 F-18

8.1.1 Overview
8.1.2 F-18: South America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)

8.2 C-11

8.2.1 Overview
8.2.2 C-11: South America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Ga68-PSMA

8.3.1 Overview
8.3.2 Ga68-PSMA: South America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)

9. South America Prostate Cancer Nuclear Medicine Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Ga68-PSMA: South America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Clinics

9.2.1 Overview
9.2.2 Ga68-PSMA: South America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)

10. South America Prostate Cancer Nuclear Medicine Market – South and Central America Analysis

10.1 South and Central America

10.1.1 South America Prostate Cancer Nuclear Medicine Market Breakdown, by Key Country, 2023 and 2028 (%)
10.1.1.1 South America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast Analysis – by Country
10.1.1.1 Brazil: South America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 Brazil: South America Prostate Cancer Nuclear Medicine Market Breakdown, by Type
10.1.1.1.2 Brazil: South America Prostate Cancer Nuclear Medicine Market Breakdown, by PET Product
10.1.1.1.3 Brazil: South America Prostate Cancer Nuclear Medicine Market Breakdown, by End User

10.1.1.2 Argentina: South America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Argentina: South America Prostate Cancer Nuclear Medicine Market Breakdown, by Type
10.1.1.2.2 Argentina: South America Prostate Cancer Nuclear Medicine Market Breakdown, by PET Product
10.1.1.2.3 Argentina: South America Prostate Cancer Nuclear Medicine Market Breakdown, by End User

10.1.1.3 Rest of South and Central America : South America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Rest of South and Central America : South America Prostate Cancer Nuclear Medicine Market Breakdown, by Type
10.1.1.3.2 Rest of South and Central America : South America Prostate Cancer Nuclear Medicine Market Breakdown, by PET Product
10.1.1.3.3 Rest of South and Central America : South America Prostate Cancer Nuclear Medicine Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. South America Prostate Cancer Nuclear Medicine Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 ImaginAb

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Curium

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 ABX advanced biochemical compounds GmbH

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Telix Pharmaceuticals Ltd

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Novartis AG

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Lantheus Medical Imaging, Inc.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights